Valneva (VALN)
(Delayed Data from NSDQ)
$7.25 USD
+0.14 (1.97%)
Updated Jul 2, 2024 02:13 PM ET
After-Market: $7.24 -0.01 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
VALN 7.25 +0.14(1.97%)
Will VALN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for VALN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VALN
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
Strength Seen in Valneva SE Sponsored ADR (VALN): Can Its 15.8% Jump Turn into More Strength?
VALN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Valneva (VALN) Stock Down 53% in the Past Year: Here's Why
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why
What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock
Other News for VALN
Positive Outlook for Valneva: Buy Rating Affirmed Amid Robust Vaccine Sales Projections
Valneva Strengthens Board, Shareholders Back Plans
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board
Valneva (0OB3) Receives a Buy from Kepler Capital
Buy Rating Justified for Valneva Amidst Ixchiq’s Strong Market Potential and Robust Financial Forecasts